MANKIND PHARMA LIMITED

Dividend Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 05:28:39 06/03/2026 pm IST			5-day change	1st Jan Change
2,187.00 ^INR	-1.77%		-2.70%	-0.43%

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE

EPS & Dividend: Mankind Pharma Limited

Fiscal Period: March	2024	2025	2026	2027	2028
Dividend per Share ²	-	-	4.017	6.229	8.117
Rate of return	-	-	0.18%	0.28%	0.37%
EPS ²	47.68	49.2	45.71	59.21	72.79
Distribution rate	-	-	8.79%	10.5%	11.2%
Reference price ²	2,300.75	2,424.75	2,187.00	2,187.00	2,187.00
Nbr of stocks (in thousands)	4,00,588	4,12,579	4,12,805	-	-
Announcement Date	15/05/24	21/05/25	-	-	-

¹INR in Million²INR

Estimates

Past dividends: Mankind Pharma Limited

08/08/2025

Ex-dividend date - 1 INR

09:30 am

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)
	MANKIND PHARMA LIMITED	0.18%	0.28%	47.85x	5.57x	6.66x
	ELI LILLY AND COMPANY	0.67%	0.74%	29.11x	17.94x	10.96x
	JOHNSON & JOHNSON	2.2%	2.33%	24.47x	6.62x	5.94x
	ABBVIE INC.	3.01%	3.13%	24.99x	72.15x	6.83x
	ROCHE HOLDING AG	2.95%	3.03%	18.18x	6.35x	4.48x
	NOVARTIS AG	2.79%	2.91%	21.57x	6.38x	5.8x
	ASTRAZENECA PLC	1.71%	1.82%	24.42x	5.55x	5.09x
	MERCK & CO., INC.	2.92%	3.01%	27.07x	5.06x	4.75x
	AMGEN INC.	2.72%	2.9%	24.86x	16.7x	6.31x
	GILEAD SCIENCES, INC.	2.26%	2.51%	19.95x	6.76x	6.07x
	Average	2.14%	2.27%	26.25x	14.91x	6.29x
	Weighted average by Cap.	2.08%	2.19%	24.89x	17.41x	7.01x

See all sector dividends

Year-on-year evolution of the Yield

Dividend / Share (DPS) - Evolution of Analysts' Estimates

More analyst reviews

Dividend / Share (DPS) - Estimates Revisions

More analyst reviews

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

More analyst reviews

Annual Profit -

Company calendar

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW